NervGen Pharma on Track to Complete Enrollment, Deliver Data Readout in Phase 1b/2a Clinical Trial for NVG-291 in Spinal Cord Injury
Stock Information for Medexus Pharmaceuticals Inc.
Loading
Please wait while we load your information from QuoteMedia.